Deaf blind hypopigmentation syndrome, Yemenite type

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3214OMIM:601706Q13.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Deaf blind hypopigmentation syndrome, Yemenite type (also known as Yemenite deaf-blind hypopigmentation syndrome or Warburg-Thomsen syndrome) is an extremely rare genetic disorder first described in Yemenite Jewish families. The condition is characterized by a triad of features affecting the eyes, ears, and skin pigmentation. Key ocular findings include microcornea, coloboma (a gap in structures of the eye such as the iris, choroid, or retina), and other anterior chamber anomalies, which can lead to significant visual impairment or blindness. Sensorineural hearing loss, which may be severe to profound, is another hallmark of the syndrome. Cutaneous hypopigmentation manifests as patchy depigmented areas of the skin, and patients may also exhibit hypopigmented patches of hair, resembling features seen in Waardenburg syndrome. The syndrome affects multiple body systems, primarily the sensory organs (eyes and ears) and the integumentary system (skin and hair). Some patients may also have additional features such as intellectual disability, though this is not uniformly present. The condition is thought to result from abnormal development and migration of neural crest cells, which contribute to melanocytes, inner ear structures, and parts of the eye during embryonic development. Due to the extreme rarity of this condition, there is no specific targeted therapy. Management is supportive and multidisciplinary, involving ophthalmologic care, hearing aids or cochlear implants for hearing loss, dermatologic monitoring, and developmental support as needed. Genetic counseling is recommended for affected families.

Also known as:

Clinical phenotype terms— hover any for plain English:

MacrodontiaHP:0001572Anterior synechiae of the anterior chamberHP:0011483TaurodontiaHP:0000679
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Deaf blind hypopigmentation syndrome, Yemenite type.

View clinical trials →

No actively recruiting trials found for Deaf blind hypopigmentation syndrome, Yemenite type at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Deaf blind hypopigmentation syndrome, Yemenite type community →

No specialists are currently listed for Deaf blind hypopigmentation syndrome, Yemenite type.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Deaf blind hypopigmentation syndrome, Yemenite type.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Deaf blind hypopigmentation syndrome, Yemenite typeForum →

No community posts yet. Be the first to share your experience with Deaf blind hypopigmentation syndrome, Yemenite type.

Start the conversation →

Latest news about Deaf blind hypopigmentation syndrome, Yemenite type

No recent news articles for Deaf blind hypopigmentation syndrome, Yemenite type.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Deaf blind hypopigmentation syndrome, Yemenite type

What is Deaf blind hypopigmentation syndrome, Yemenite type?

Deaf blind hypopigmentation syndrome, Yemenite type (also known as Yemenite deaf-blind hypopigmentation syndrome or Warburg-Thomsen syndrome) is an extremely rare genetic disorder first described in Yemenite Jewish families. The condition is characterized by a triad of features affecting the eyes, ears, and skin pigmentation. Key ocular findings include microcornea, coloboma (a gap in structures of the eye such as the iris, choroid, or retina), and other anterior chamber anomalies, which can lead to significant visual impairment or blindness. Sensorineural hearing loss, which may be severe to

How is Deaf blind hypopigmentation syndrome, Yemenite type inherited?

Deaf blind hypopigmentation syndrome, Yemenite type follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Deaf blind hypopigmentation syndrome, Yemenite type typically begin?

Typical onset of Deaf blind hypopigmentation syndrome, Yemenite type is neonatal. Age of onset can vary across affected individuals.